Trial advancing with ongoing safety and pharmacologic evaluation and planned expansion into MDS and MFSOUTH SAN FRANCISCO, Calif., March 30, ...
Siliconera on MSN
FFXIV CERO age rating goes up in Japan
Square Enix announced that the Japanese CERO age rating for FFXIV will change with the upcoming Patch 7.5. The current CERO ...
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is ...
SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of ...
Ongoing activities, including new engagement to relist on Nasdaq, new board member, continued advancement of Phase 1 trial into MDS patients, strategic engagement, and continued support from lead ...
CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are racing higher Thursday after the company announced the publication of preclinical research on the use of its clinical candidate CER-1236 to ...
CERO, the Computer Entertainment Rating Organization, announced it will resume activities on May 7. In a statement published on May 4, the organization announced it will start rating Japaneses games ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results